Adrenomed Ag Is A German Clinical Stage Biopharmaceutical Company Based In Hennigsdorfbrandenburgfounded In 2009The Company Focuses On Developing Precision Medicine Solutions For Critically Ill Patientsparticularly Those Suffering From Sepsis And Septic Shockadrenomed Specializes In Therapies That Target Vascular Integrityaiming To Improve Survival Rates In Life Threatening Conditions Through Biomarker Guided Approaches The Company S Lead Productadrecizumabenibarcimab Is A First In Class Monoclonal Antibody That Targets The Vasoprotective Peptide Adrenomedullinit Has Successfully Completed A Phase Ii Trial Involving 301 Patientsdemonstrating Its Potential In A Biomarker Guidedrandomizedplacebo Controlled Studyadrenomed Is Committed To Advancing Adrecizumab Through Further Clinical Development And Regulatory Preparationssupported By Significant Funding From Investorsthe Company Collaborates With Healthcare Providers And Institutions To Optimize Patient Outcomes In Acute Care Settings
| Company Name | Adrenomed Ag |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States